Improving treatment for pancreatic cancer using advanced imaging and blood tests
Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy
This study is looking at new ways to better manage pancreatic cancer by using advanced imaging and blood tests to quickly see how well treatments are working, so doctors can make faster decisions about care and help more patients get the right treatment when they need it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11193860 on NIH RePORTER |
What this research studies
This research focuses on enhancing the management of pancreatic ductal adenocarcinoma (PDA) by utilizing next-generation imaging techniques and liquid biopsies. The goal is to provide timely and accurate assessments of treatment responses, allowing for quicker adjustments to therapies and better identification of patients who may benefit from surgery. By integrating these advanced tools, the research aims to improve patient outcomes by ensuring that effective treatments are administered promptly while minimizing unnecessary toxicities from ineffective therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with pancreatic ductal adenocarcinoma, particularly those with nonresectable or metastatic disease.
Not a fit: Patients with pancreatic cancer who are already in the late stages of the disease with no treatment options may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment strategies for patients with pancreatic cancer, potentially improving survival rates.
How similar studies have performed: Other research has shown promise in using advanced imaging and liquid biopsy techniques for cancer management, indicating that this approach could be effective.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Collisson, Eric — Fred Hutchinson Cancer Center
- Study coordinator: Collisson, Eric
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.